Trials / Completed
CompletedNCT00904085
Post-operative Efficacy and Safety Study
A Randomized, Double-blind Evaluation of the Analgesic Efficacy and Safety of a Low Dose Oxymorphone Immediate Release in Patients Following Ambulatory Arthroscopic Knee Surgery
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 122 (actual)
- Sponsor
- Endo Pharmaceuticals · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study was to compare the analgesic efficacy of 5 mg oxymorphone IR with placebo in patients with mild to moderate pain following outpatient knee arthroscopy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Oxymorphone IR | 5 mg |
Timeline
- Start date
- 2003-04-01
- Primary completion
- 2003-06-01
- Completion
- 2003-06-01
- First posted
- 2009-05-19
- Last updated
- 2010-02-15
Source: ClinicalTrials.gov record NCT00904085. Inclusion in this directory is not an endorsement.